Scientific Program | 2023 CGA-IGC Annual Meeting - The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer

Scientific Program

Please click here to view the scientific program at a glance in PDF.

Legend	Scientific Sessions
	Sponsored Sessions
	Committee Meetings
	Abstracts
	Social Events

Main Hall

08:00 - 08:15	Welcome & Housekeeping Peter Stanich, CGA-IGC President
08:15 - 09:45	Hereditary GI Across Ages *Moderators: Megha Ranganathan & Jill Genua* Extent of Surgery in Early and Late Onset Cancer (Sporadic and Lynch), *Nancy You* Q&A When to stop screening in Older Adults with Hereditary GI syndromes?, *Armin Shahrokni* Q&A How We Do It: Pediatric Polyposis Clinic and Transition to Adult Care, *Steve Erdman & Kristin Zajo & Molly Gardner & Colleen Flahive* Q&A
09:45 - 10:00	Break
10:00 - 11:20	Anne Krush Lecture *Moderators: Cathryn Koptiuch* Krush Introduction Counseling of Children for Adult Onset Conditions, Leila Jamal Q&A Patient Perspective on Young Onset Cancer and Genetic Testing, *Danielle Ripley-Burgess* Q&A
11:20 - 11:30	Break: Coffee & Snacks
11:30 - 12:30	JEDI Moderators: Lauren Gima & Gregory Idos Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing, Nicolette Rodriguez & Charité Ricker Diversity in Genetic Providers: Where Are We and How Do We Improve?, *John Carethers* Panel Q&A
12:30 - 14:00	Lunch Break
12:45 - 13:45	Sponsored Lunch Industry Session 1
14:00 - 15:30	Presidential Plenary I *Moderators: Swati Patel & Peter Stanich* O-001 - The immune profile of Lynch syndrome-associated colorectal adenomas pinpoints the main determinants of immune activation, *Lena Bohaumilitzky* O-002 - Who falls between the cracks? Geographic analysis and factors associated with genetic testing completion in colorectal cancer patients, *Mary G. Smithson* O-003 - Racial Disparities in Tumor Microbiome in Young-Onset and Average-Onset Colorectal Cancer, *David Liska* O-004 - Genetic Etiology of Constitutional {MLH1} Promoter Hypermethylation: Sixteen-Year Experience from a Single Diagnostic Laboratory, Megan F Hoenig O-005 - Outcomes of the IMMray PanCan-d™ test in high-risk individuals undergoing pancreatic surveillance: Pragmatic data and lessons learned, *Bryson W Katona* O-006 - Determinants of Signet Ring Cell Carcinoma in Hereditary Diffuse Gastric Cancer, Ophir Gilad
	Break: Coffee & Snacks
15:30 - 16:15	CCARE Lynch Poster Walk Moderators: Elena Levinson & Fay Kastrinos P-065 One of these is not like the others: a descriptive study of the attenuated phenotype of PMS2, Brandie Heald P-081 Colorectal cancer risk factors in Lynch syndrome: {MSH2}, advanced adenomas and adenomas multiplicity, Joaquin Castillo P-083 Attitudes towards prevention options in Lynch Syndrome (LS): comparing frameshift peptide vaccination (FSPVAX), colonoscopy (COLO), and aspirin (ASA), Michael Hall P-092 Cost-effectiveness of universal germline vs sequential screening for Lynch syndrome in patients with incident colorectal cancer in the United States, Xavier Llor P-033 Frequency of Mismatch Repair Tumor Deficiency and Lynch Syndrome in Diverse Colorectal Cancer Patients at a Safety-Net Medical Center, Yvonne Cardona
16:15 - 17:40	Gastric Cancer Moderators: Maegan Roberts & Carol Burke Gastric Cancer Risk and Screening Recommendations in Hereditary Breast Cancer Syndromes, Bryson Katona Q&A Debate Format Introduction & Audience Poll Early surgical management in CDH1, Sonia Kupfer Extended endoscopic surveillance in CDH1, Massimiliano di Pietro Cross Examination by Moderators and Rebuttals Q&A
18:00 - 19:00	Poster Session I

Main Hall

07:00 - 07:45	Sponsored Breakfast Industry Session 2
08:00 - 08:15	Welcome Peter Stanich, CGA-IGC President
08:15 - 09:45	Lynch Syndrome Moderators: Dana Zakalik & Robert Hüneburg Amsterdam 2 Criteria and Modern Practice, Heather Hampel Q&A Prevention in Lynch: Tips for Clinical Practice, Ajay Bansal Q&A How We Do It: Optimization of the EHR for Lynch Syndrome, Danielle McKenna & Jessica Long & Lauren Schwartz Q&A
09:45 - 10:00	Break: Coffee & Snacks
10:00 -11:00	Jagelman–Church Lecture *Moderator: Mohammed Abbass* Jagelman-Church Intro Non-Operative Management of Rectal Cancer from the Surgery Point of View, *Jesse Joshua Smith* Q&A
11:00 - 12:00	South American Update *Moderators: Jose Guillem & Nicolette Rodriguez* Update from LA-GETH, Luciana Laje Mejia Zapata & Mev Dominguez Valentin Collaboration throughout the Americas Panel, Luciana Laje Mejia Zapata & Mev Dominguez Valentin O-007 - Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals with Gastrointestinal Cancer or Polyps Undergoing Testing, Daniel E. Pineda Alvarez
12:00 - 13:30	Lunch Break
12:15 - 13:15	Sponsored Lunch Industry Session 2
13:30 - 15:00	Presidential Plenary II *Moderators: Peter Stanich & Bryson Katona* O-008 - Use of digital health tools with point-of-care testing improves access to germline genetic testing within a gastrointestinal cancer clinic, Catherine Smith O-009 - Pathogenic germline variants and Lynch Syndrome in patients with endometrial cancer across diverse ancestries, Ying Liu O-010 - PGT-M for hereditary cancer conditions - a 12-year testing experience at a single reference laboratory, Jeannie Klavanian O-011 - Characterizing Gastrointestinal Clinicopathological Features in Children with {PTEN} Hamartoma Tumor Syndrome: A Bi-institutional Study, Darren Liu O-012 - Yield of genetic testing in patients with a family history of pancreatic cancer in a publicly funded hereditary cancer program, Carol Mary Cremin O-013 - “Should I let them know I have this?”: Experiences with genetic discrimination amongst patients with hereditary cancer syndromes, Kasmintan Schrader
15:00 - 15:30	Break: Coffee & Snacks
15:30 - 17:00	Updates from the Experts *Moderators: Rachel Hodan & Joanne Jeter* Hereditary Non-adenocarcinoma GI Cancer Syndromes, Justin Annes Q&A NCCN Guidelines Update, Samir Gupta Q&A MiGHT and Cascade Testing Approaches, Elena Stoffel Q&A
17:00 - 18:00	Jeopardy Moderators: Maureen Mork & Michael Hall
18:00 - 19:00	Poster Session II

Main Hall

08:00 - 08:15	Welcome Peter Stanich, CGA-IGC President
08:15 - 09:20	Polyposis Syndromes *Moderators: Aparajita Singh & Matthew Kalady* Endoscopic Management of the Foregut in FAP, Gautam Mankaney Q&A Surgical Treatment of Polyposis: the (not so) Good, the Bad, and the Ugly, Paul Wise Q&A
09:20 - 10:20	Randall Burt Lecture *Moderator: Maureen Mork* Burt Introduction Chemoprevention in Polyposis: Past, Present and Future, Patrick Lynch Q&A
10:20 - 11:00	Break: Coffee & Snacks
11:00 - 12:00	Conquering Clinical Challenges *Moderators: Julie Moskowitz & Colleen Flahive* How We Do It: Precision Medicine for All Cancer Patients, Heather Hampel & Gregory Idos & Deborah Harwood & Lauren Gima Q&A Hereditary Live! and In Person, Intro & Moderator: Joshua Sommovilla Panelists: Paul Wise, Jennifer Weiss, Emma Keel Case 1, Olga Lavryk & Sarah McGee Case 2, Ajay Bansal
12:00 - 13:30	Lunch Break
12:15 - 13:15	Mentorship Lunch (By Invitation Only)
13:30 - 15:00	Presidential Plenary III *Moderators: Bryson Katona & Beth Dudley* O-014 - Lynch Syndrome (LS) Patients with Inflammatory Bowel Disease (IBD) Have Significantly Higher Intestinal Neoplasia Risk than LS Patients without IBD, Abigail Braun O-015 - Adenoma prevalence and incidence in Lynch syndrome do not differ between genes, Joaquin Castillo O-016 - HLA Type as a possible modulator of cancer risk in Lynch syndrome: first data from the INDICATE Network, Matthias Kloor O-017 - Exploring stakeholders’ perspectives on implementing universal germline testing for colorectal cancer: Findings from a clinical practice survey, Sanjeevani Arora O-018 - Outcomes of patients with Lynch syndrome undergoing restorative proctocolectomy with ileal pouch-anal anastomosis, Olga Lavryk O-019 - Duodenal disease in MUTYH-associated polyposis: updated findings from an international prospective study, Laura E Thomas
15:00 - 16:00	CGA-IGC Business Meeting & Presidential Transition Peter Stanich, CGA-IGC President & Michael Hall Post Meeting Wrap Up Bryson Katona

Subscribe to Get Connected